Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix Reports Second Quarter 2014 Financial Results and Business Highlights

Business Wire July 24, 2014

NeuroMetrix Marks 10th Year Anniversary of Listing on NASDAQ

Business Wire July 22, 2014

NeuroMetrix, Inc. Announces Date for 2014 Second Quarter Financial Results Conference Call

Business Wire July 17, 2014

FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain

Business Wire July 8, 2014

NeuroMetrix Announces $8 Million Preferred Stock Placement

Business Wire June 24, 2014

NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck

Business Wire June 24, 2014

NeuroMetrix Submits Regulatory Application for NC-stat DPNCheck in China

Business Wire June 10, 2014

NeuroMetrix to Exhibit at American Diabetes Association's 74th Scientific Sessions

Business Wire June 3, 2014

NeuroMetrix Reports Japan Marketing Launch for NC-stat DPNCheck

Business Wire May 22, 2014

NeuroMetrix to Exhibit at International Meeting

Business Wire May 7, 2014

NeuroMetrix and SENSUS Pain Management System Spotlighted In Media Outlets and Patient Interviews

Business Wire April 29, 2014

NeuroMetrix Reports First Quarter 2014 Financial Results and Business Highlights

Business Wire April 24, 2014

NeuroMetrix, Inc. Announces Date for 2014 First Quarter Financial Results Conference Call

Business Wire April 16, 2014

Direct Global Media Re-Initiates Coverage on EKO International (EKNL) and Provides Additional Update on the Cannabis and Medical Marijuana Featured Company HEMP Inc. (HEMP)

Marketwired April 14, 2014

Direct Global Media Re-Initiates Coverage on EKO International (EKNL) and Provides Additional Update on the Cannabis and Medical Marijuana Featured Company HEMP Inc. (HEMP)

Marketwired April 14, 2014

NeuroMetrix Initiates Patient-Focused Program for Early Detection of Diabetic Peripheral Neuropathy by Podiatrists

Business Wire April 1, 2014

NeuroMetrix Launches Second Generation SENSUS Device

Business Wire March 18, 2014

NeuroMetrix Submits Regulatory Application for NC-stat DPNCheck in Japan

Business Wire March 11, 2014

NeuroMetrix CEO Dr. Shai N. Gozani Interviewed Live on TuDiabetes.org

Business Wire March 7, 2014

NeuroMetrix Reports Publication of Study Demonstrating that NC-stat DPNCheck is Effective at Detecting Diabetic Peripheral Neuropathy

Business Wire March 3, 2014